113 related articles for article (PubMed ID: 37401481)
21. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.
Wheeler JM; Kim HC; Efstathiou JA; Ilyas M; Mortensen NJ; Bodmer WF
Gut; 2001 Mar; 48(3):367-71. PubMed ID: 11171827
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.
Abudukadeer A; Bakry R; Goebel G; Mutz-Dehbalaie I; Widschwendter A; Bonn GK; Fiegl H
Int J Mol Sci; 2012; 13(7):8353-8363. PubMed ID: 22942707
[TBL] [Abstract][Full Text] [Related]
23. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
[TBL] [Abstract][Full Text] [Related]
24. CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion.
Zazula M; Ferreira AM; Czopek JP; Kolodziejczyk P; Sinczak-Kuta A; Klimkowska A; Wojcik P; Okon K; Bialas M; Kulig J; Stachura J
Diagn Mol Pathol; 2006 Mar; 15(1):24-9. PubMed ID: 16531765
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
26. Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.
Toyooka KO; Toyooka S; Maitra A; Feng Q; Kiviat NC; Smith A; Minna JD; Ashfaq R; Gazdar AF
Am J Pathol; 2002 Aug; 161(2):629-34. PubMed ID: 12163387
[TBL] [Abstract][Full Text] [Related]
27. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas.
Carvalho B; Pinto M; Cirnes L; Oliveira C; Machado JC; Suriano G; Hamelin R; Carneiro F; Seruca R
Eur J Cancer; 2003 Jun; 39(9):1222-7. PubMed ID: 12763209
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
[TBL] [Abstract][Full Text] [Related]
29. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
30. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.
Yamada H; Shinmura K; Goto M; Iwaizumi M; Konno H; Kataoka H; Yamada M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
Mol Cancer; 2009 Aug; 8():63. PubMed ID: 19671196
[TBL] [Abstract][Full Text] [Related]
31. CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18.
Rosendo-Chalma P; Antonio-Vejar V; Bigoni-Ordóñez GD; Patiño-Morales CC; Cano-García A; García-Carrancá A
Int J Oncol; 2020 Jul; 57(1):301-313. PubMed ID: 32319591
[TBL] [Abstract][Full Text] [Related]
32. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
[TBL] [Abstract][Full Text] [Related]
33. Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma.
D'Urso PI; D'Urso OF; Storelli C; Catapano G; Gianfreda CD; Montinaro A; Muscella A; Marsigliante S
J Neurooncol; 2011 Aug; 104(1):113-8. PubMed ID: 21127944
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic Regulation of CDH1 Is Altered after HOXB7-Silencing in MDA-MB-468 Triple-Negative Breast Cancer Cells.
Paço A; Leitão-Castro J; Freitas R
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680970
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
37. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.
Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M
Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309
[TBL] [Abstract][Full Text] [Related]
38. Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori.
Kague E; Thomazini CM; Pardini MI; Carvalho Fd; Leite CV; Pinheiro NA
Arq Gastroenterol; 2010; 47(1):7-12. PubMed ID: 20520968
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
40. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]